How has been the historical performance of Nexus Surgical?

Answer:The historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years.

Breakdown:
Nexus Surgical's net sales have increased from 1.55 Cr in Mar'23 to 5.72 Cr in Mar'25, indicating strong growth. The total operating income followed a similar trajectory, rising from 1.55 Cr in Mar'23 to 5.72 Cr in Mar'25. The company's total expenditure also increased, but at a slower pace, from 1.34 Cr in Mar'23 to 5.06 Cr in Mar'25, resulting in an operating profit (PBDIT) that improved from 0.21 Cr in Mar'23 to 0.67 Cr in Mar'25. Profit before tax also saw a rise from 0.23 Cr in Mar'23 to 0.67 Cr in Mar'25, leading to a profit after tax of 0.50 Cr in Mar'25, up from 0.17 Cr in Mar'23. The earnings per share (EPS) increased significantly from 0.31 in Mar'23 to 0.91 in Mar'25, reflecting improved profitability. On the balance sheet, total assets grew from 0.91 Cr in Mar'23 to 2.27 Cr in Mar'25, while total liabilities increased from 0.91 Cr to 2.27 Cr in the same period. The book value per share also improved from 0.65 in Mar'23 to 1.94 in Mar'25, indicating a strengthening financial position. Overall, Nexus Surgical has demonstrated robust growth in sales and profitability, alongside an improving balance sheet.